Header Logo

Connection

HUSSEIN TAWBI to Vascular Endothelial Growth Factor Receptor-2

Back to Details
This is a "connection" page, showing publications HUSSEIN TAWBI has written about Vascular Endothelial Growth Factor Receptor-2.
HUSSEIN TAWBI
Connection Strength
0.037
Vascular Endothelial Growth Factor Receptor-2
  1. NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma. Cancer. 2018 11 15; 124(22):4332-4341.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.